As miRNAs are increasingly being identified as cancer biomarkers and their expression and sequence profiles can distinguish between normal and tumor tissues (Lu et al. 2005), existence of such competing isomiR populations and TUT4/7-mediated cell-type-specific regulatory networks that control their expression levels hold clues to cancer progression. The gene discussed is TUT4; the disease is cancer.